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INTRODUCTION
 Cancer is a leading cause of mortality 
worldwide, though a rare event during 
pregnancy. The annual incidence is reported to 
be approximately 1/1,000 pregnancies, which 
only makes 0.07% to 0.1% of all malignant 
tumors.1 This incidence is expected to increase 
due to delay in child bearing age. The common 
malignancies noted in pregnant women are 
brain, breast cancer, lymphomas, leukemia’s, 
cervical and ovarian cancer.2
 The pathophysiology of cancer during 
pregnancy is poorly understood. Theoretically, 
hormonal and immunological variations with an 
increase in permeability and vascularization are 
thought to affect cancer prognosis and survival.3 
Also, the outcomes are dependent on the type 
and stage of cancer. Few studies have reported 
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ABSTRACT
Objectives: To assess the overall survival of pregnant women diagnosed with cancer during pregnancy or 
became pregnant thereafter.
Methods: A retrospective medical record review of 90 patients who were diagnosed with cancer when 
pregnant or who became pregnant thereafter between 1996 and 2015 in Aga Khan University Hospital, 
Karachi. 
Results: A total of 90 patients were analyzed. The malignancies that expectant mothers had were, breast 
cancer 38 (42.2%), hematological cancers 29 (32.2%), brain cancer 10 (11.1%), and other malignancies 13 
(14.4%) that included thyroid cancers, gestational trophoblastic disease and synovial tumor of foot. We 
observed only four deaths out of 90 patients and mean survival time in pregnant patients with malignancies 
was 17.98 years [CI 16.35-19.31].  
Conclusions: The diagnosis of most cancer types before or during pregnancy does not influence on overall 
survival of patients. 
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a reduced survival rate in this group of women.2 
However, there are contradictory findings in 
other studies.4,5
 According to our knowledge no local data exists 
about survival in pregnant women with cancer. 
Hence the rationale of this study is to help our 
health care providers in the management of these 
women and enable them to counsel regarding 
prognosis and survival.
METHODS
 This was a retrospective observational study 
conducted in the department of Obstetrics & 
Gynecology, Aga Khan University Hospital 
Pakistan (AKUH). Medical records of the patients 
diagnosed with cancer during pregnancy and 
thereafter from 1996-2015 were reviewed in 2018. 
Inclusion criteria included all pregnant women 
with histologically confirmed malignant cancer 
before and during pregnancy with sufficient 
retrievable records code according to ICD-9 
codes (International Classification of Diseases, 
9th revision) system. The Hospital Information 
Management System (HIMS) at AKUH codes 
all inpatient medical records for diagnosis 
and procedure according (ICD-9-CM) coding 
system.  Solid cancer Cases coded between 140.0 
-195.8, whereas Hematological malignancies were 
coded from 2.200.00 to 209.29.
 Data was collected on Pre-tested structured 
questionnaire after approval from Ethics 
Review Committee (ERC) of Aga Khan Hospital. 
Medical record files were reviewed for each case. 
Patient data comprised of basic demographic 
characteristics, obstetric/medical history, cancer 
diagnosis on registration, stages and grades of 
cancer, treatment administered and outcome. 
Data analysis was performed using SPSS version 
19. Frequencies (percentages) were estimated for 
categorical variables. Overall survival analysis 
was conducted by using the Kaplan–Meier 
method.
Operational Definition: Overall survival rate: 
Overall survival rate is percentage of people 
who survive a certain type of cancer for a specific 
period of time.6
RESULTS
 A total of 120 pregnant women with 
malignancies of different sites were registered 
at Aga Khan University Hospital between 1998 
and 2015. Out of the total, 30 patient’s records 
had incomplete information regarding course 
of disease and therefore were excluded from 
the study. Five patients were lost to follow up. 
Ninety patients were included. 
 The common malignancies that expectant 
mothers had were; breast cancer 38(42.2%), 
hematological cancers 29(32.2%), brain tumor 
10(11.1%), and other malignancies 13(14.4%) 
including thyroid cancers, gestational 
trophoblastic disease and synovial tumor of foot. 
(Table-I). We observed only 4 deaths out of 90 
patients in our study. These deaths were found 
in patient with breast cancer and hematological 
malignancies.
 Most of the patients were more than thirty 
years of age i.e. 50 (55.6%), however, majority 
women diagnosed with blood cancer patients 
were less than thirty years of age i.e., 18 (45%). 
More than half of the patients 63(70%) were 
multigravida. Approximately, 50% of women 
with breast and blood cancers also had history 
of more than two miscarriages. (Table-I).
 Standard treatment modalities were used in all 
women with malignancies. 17 (60.7%) of patients 
with breast cancer, 6 (21.4%) of patients with 
Table-I: Characteristics of Patients (n=90).
 Breast CA Brain CA Hem/Onc Others
 38(42.2%) 10(11.1%) 29(32.2%) 13(14.4%)
Age
<30 years 10 (25%) 5 (12.5%) 18 (45%) 7 (17.5%)
>30 years 28 (56%) 5 (10%) 11 (22%) 6 (12%)
Parity
Primigravida 3 (30%) 1 (10%) 3 (30%) 3 (30%)
Multigravida  31 (49.2%) 6 (9.5%) 17 (27%) 9 (14.3%)
   (>2)
Grand 4 (23.5%) 3 (17.6%) 9 (52.9%) 1 (5.9%)
   multigravida (>5)
Miscarriages
<2 36 (41.9%) 10(11.6%) 27(31.4%) 13(15.1%)
>2 2 (50%) 0 2 (50%) 0
Treatment
Surgery 17 (60.7%) 6 (21.4%) 0 5 (17.9%)
Chemotherapy 21 (38.9%) 4 (7.4%) 23(42.6%) 6 (11.1%)
Hydroxyurea 0 0 6 (100%) 0
No treatment 0 0 0 2 (100%)
Stage
Stage 1 10 (66.7%) 2 (13.3%) 0 3 (20%)
Stage 2 17 (58.6%) 5 (17.2%) 3 (10.3%) 4 (13.8%)
Stage 3 4 (44.4%) 2 (22.2%) 0 3 (33.3%)
Stage 4 7 (18.9%) 1 (2.7%) 26(70.3%) 3(8.1%)
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brain tumor, 5 (17.9%) with other malignancies 
had surgery before pregnancy. While, 21 (38.9%) 
of breast cancer patients, 4 (7.4%) of patients with 
brain tumor, 23 (42.6%) of blood cancer patient, 
6 (11.1%) of patients with other malignancies 
received chemotherapy.
 Most of pregnant patients with blood cancer 
were in staged IV i.e. 26 (70.3%). Most frequently 
found stage for breast cancer was stage I 
infiltrating ductal carcinoma i.e. 10 (66.7%). As 
shown in survival curve (Fig.1) mean survival 
time in the patients with malignancies was found 
to be 17.98 years [CI 16.35-19.31].
DISCUSSION
 The present study was performed to determine 
the common cancer types in pregnant women 
in our population and their characteristics 
and the effect of pregnancy on cancer survival 
in our setting. The cancer types which were 
commonly observed in our cohort were breast 
cancer, leukemias, lymphomas and brain tumors, 
consistent with the results of Palvidis et al.7
 Till 2018 the cumulative survival time in our 
subjects was found to be 17.98 years. Which is 
consistent with one nationwide, registry-based 
study on most frequent cancer diagnoses during 
pregnancy and lactation. This confirms diagnosis 
of cancer during pregnancy or lactation does 
not increase the risk of cause-specific death 
compared with control group.
 The most frequent tumor seen in these women 
was breast cancer. Majority of them were 
diagnosed during pregnancy. The reason might 
be as they have their first examination from a 
healthcare provider during pregnancy and thus 
are diagnosed late, which is contrary to the 
data from developed countries where national 
screening program are well established.8 In our 
patients with breast cancer, the most common 
type was Infiltrating Ductal Carcinoma (IDC), 
diagnosed at Stages I and II. Most of these 
patients received chemotherapy during second 
and third trimester whereas seventeen (60.7%) 
patients were planned to have breast cancer 
surgery at the time of cesarean section. Overall 
survival of this group showed healthy mother 
effect and these results are consistent with Iqbal 
J et al study that showed pregnancy did not 
adversely affect survival in women with breast 
cancer.9
 In our study, hematological malignancies 
observed were leukemia, lymphomas and 
essential thrombocytosis. Due to some 
incomplete information, the effect of histological 
type and stage could not be assessed on overall 
survival rate of these patients. We had twenty 
nine women in this group, out of which nineteen 
cases were diagnosed before pregnancy and ten 
during pregnancy. Among these patients, twenty 
three (42.6%) received chemotherapy and six 
(100%) cases of essential thrombocytosis received 
hydroxyurea before pregnancy. From this group 
of patients, three women underwent termination 
of pregnancy as the chemotherapy was planned 
to start in the first trimester of pregnancy. Our 
findings suggest that prognosis of hematological 
malignancies during pregnancy is comparable 
to non-pregnant women, and usually good for 
those who received chemotherapy in the second 
half of pregnancy. This is in agreement with 
Hossam K et al findings.10 That also embarked 
upon the importance of gestational age at 
diagnosis, stage of malignancy and teratogenicity 
of chemotherapeutic agent during pregnancy, if 
chemotherapy is necessary during first trimester 
then termination of pregnancy is generally 
indicated, But the outcome is usually good for 
those patients who receive chemotherapy in the 
second or third trimester.
 The third most common cancer in our study 
was glial tumor of brain. It included, five patients 
with Grade-II astrocytoma, three had Grade-II 
and III oligodendroglioma and two had Grade-II 
Pregnancy and cancer survival
Fig.1: Survival analysis.
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ependymoma. Majority of them had post cancer 
pregnancies except two who were diagnosed 
during pregnancy with Grade-II astrocytoma and 
Grade-II oligodendroglioma, respectively. Out 
of total, six (21.4%) patients underwent surgery 
before pregnancy and four (7.4%) patients 
received chemotherapy. None of the patients had 
disease progression during pregnancy; which is 
consistent with Rønning PA study, that showed 
pregnancy have no impact on the survival of 
patients with Low grade gliomas.11
 Other tumors included gestational trophoblastic 
disease, thyroid cancers and synovial foot tumor, all 
these pregnancies occurred after the treatment of the 
cancer. Similar to other studies regarding thyroid 
cancer and gestational trophoblastic diseases,12,13 
we did not found statistically significant difference 
in overall survival for pregnant women.
 There were four mortalities in our cohort. Two 
of these patients died of advanced stage breast 
cancer (stage IV and Stage III IDC, respectively). 
Both of these patients had full term deliveries 
with mean survival time of two years. The third 
mortality was of patient with Stage IV IDC who 
underwent termination of pregnancy at six weeks 
and survived for one year.  This leads to belief 
that the extent of the disease at diagnosis has an 
impact on survival.  Fourth case was in a woman 
with acute myeloid leukemia diagnosed in second 
trimester of pregnancy and delivered at term. She 
died after sixteen years due to sepsis.
 The strength of our study is the compliance of 
our patients for long term follow up. The reason 
for this could be as the study was conducted in a 
private, fully-equipped, centrally-located, tertiary 
care hospital, also catering patients referred from 
remote areas.
Limitations of the study: It includes limited number 
of patients and its retrospective nature. In a few 
cases the information was missing about certain 
details related to extent and course of the disease. 
However, it was not associated with significant 
impact on the overall survival analysis of these 
patients.
CONCLUSIONS
 The diagnosis of most cancer types before or 
during pregnancy has no influence on overall 
survival of patients.
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